Home » Topics » Regulatory » Patents

Patents
RSS

Triazine-based adenosine antagonists in development at Boehringer Ingelheim

April 29, 1999

New CRF antagonists described by DuPont for stress-related disorders

April 29, 1999

Potent, optically pure analogues of camptothecin designed at SCRAS

April 29, 1999

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

U.S. patent issued to NitroMed, providing protection for MED/FSAD treatment program

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

Kissei designs new series with potent and selective bronchodilating effects

April 28, 1999

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...